RecruitingNCT03964480

Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.


Sponsor

Associazione Angela Serra per la ricerca sul cancro

Enrollment

1,000 participants

Start Date

Oct 14, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

This study T-Cell Project 2.0 is based on the former International PTCL study designed by the International T-cell Non-Hodgkin's Lymphoma Study Group (T-Cell Project 1.0: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma) as a prospective collection of data to predict the prognosis of patients with the more frequent subtypes of PTCL. It is a prospective, longitudinal, international, observational study of patients with newly diagnosed peripheral T-cell lymphoma aiming to verify whether this prospective collection of data would allow achieving a more accurate information on T-cell lymphomas. The study aims to better define the clinical relevance of the new WHO Classification, the role of FDG-PET in staging and response assessment, the prognosis of different entities, the genomic landscape of different subtypes, and to investigate on most optimal treatment strategies for these neoplasms in the real-world population as well as molecular markers and to explore the prognostic or predictive implications of them in PTCL. The study aims to better define the clinical relevance of the new WHO Classification, the role of FDG-PET in staging and response assessment, the prognosis of different entities, the genomic landscape of different subtypes, and to investigate on most optimal treatment strategies for these neoplasms in the real-world population.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is an international registry study that collects data on newly diagnosed patients with peripheral T-cell lymphoma (PTCL) or NK/T-cell lymphoma — rare and aggressive blood cancers. The registry tracks treatment choices and outcomes across multiple countries to help researchers understand what therapies work best for these uncommon cancers. **You may be eligible if...** - You have been newly diagnosed with a peripheral T-cell or NK/T-cell lymphoma (including subtypes like adult T-cell leukemia/lymphoma, angioimmunoblastic T-cell lymphoma, PTCL not otherwise specified, and others) - You have not yet received treatment for this diagnosis - You are at any age - You are willing to have your treatment and outcome data collected **You may NOT be eligible if...** - You have a T-cell lymphoma that does not fall into the PTCL/NK-T cell categories (e.g., cutaneous T-cell lymphoma) - You have already received treatment before enrollment - You are unwilling to provide consent for data collection Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(6)

Stanford University

Stanford, California, United States

IRCCS Istituto Tumori "Giovanni Paolo II"

Bari, Italy

Palermo_La Maddalena

Palermo, Italy

Terni-Santa Maria

Terni, Italy

Cluj Napoca_Ion Chiricuta Oncology Institute

Cluj-Napoca, Romania

National Cancer Institute

Kiev, Ukraine

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03964480


Related Trials